HSHHSH Health Technology Supplier Hub
Home › Suppliers › Fujitsu

Fujitsu

HQ Japan · Asia-Pacific

Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.

At a glance

Financial health
Band: Not assessed
Customer rating
No reviews yet

Financial health

Band: Not assessedListed: 6702.T

Listed (6702.T).

Latest full-year results not yet captured by HSH.

Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.

Products & services

Products not yet catalogued.

Financial

Listed (6702.T).

Latest full-year results not yet captured by HSH.

Researched 8 Nov 2026

Adverse media

Jul 2025: the Post Office Horizon Inquiry published its first report; Fujitsu said it had a moral obligation to contribute to redress. Mar 2026: the Business and Trade Committee said Fujitsu had yet to pay anything toward the near £2bn compensation bill.

Researched 10 Nov 2026

Cyber & information governance

No data breaches, cyber incidents or regulator action involving Fujitsu found in HSH's search of the last 24 months. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

IT services supplier; no regulatory or clinical safety actions found in the last 24 months.

Researched 10 Nov 2026

Contract performance

Jan 2026: Fujitsu won places on a £984m SSEN Transmission digital framework despite its 2024 pledge to pause bidding for new UK public sector work; Fujitsu said the pledge did not apply. Jul 2025: The Register reported it was still winning UK government contracts.

Researched 10 Nov 2026

Competitors

No competitors linked yet.

Customer reviews

No reviews yet